Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ALIMERA SCIENCES INC | 4,428,091 | reported | 26 Oct 2015 | tx 6+60,364 |
| Syros Pharmaceuticals, Inc. | 1,466,654 | reported | 06 Jul 2016 | tx 6+2,095,220−1,695,220 |
| REGENXBIO Inc. | 1,256,542 | reported | 22 Sept 2015 | tx 7+1,344,042−1,169,042 |
| XERIS PHARMACEUTICALS INC | 1,000,000 | reported | 25 Jun 2018 | tx 6+2,498,666−3,114,584 |
| Editas Medicine, Inc. | 954,700 | reported | 08 Feb 2016 | tx 5+1,809,400−1,709,400 |
| Q32 Bio Inc. | 518,827 | reported | 28 Jan 2020 | tx 3−639,506 |
1 purchase reported after at least 12 months of silence — most recent on 25 Jun 2018.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Jan 2020 | SALE | Q32 Bio Inc. | 193,359 | 15.77 USD | |
| 28 Jan 2020 | SALE | Q32 Bio Inc. | 65,891 | 15.51 USD | |
| 24 Jan 2020 | SALE | Q32 Bio Inc. | 380,256 | 15.69 USD | |
| 25 Jun 2018 | PURCHASE | XERIS PHARMACEUTICALS INC | 125,667 | 15.00 USD | first after silence |
| 25 Jun 2018 | CONVERSION | XERIS PHARMACEUTICALS INC | 874,333 | — | |
| 25 Jun 2018 | CONVERSION | XERIS PHARMACEUTICALS INC | 874,333 | — | |
| 25 Jun 2018 | PURCHASE | XERIS PHARMACEUTICALS INC | 624,333 | 15.00 USD | |
| 25 Jun 2018 | CONVERSION | XERIS PHARMACEUTICALS INC | 1,557,292 | — | deriv |
| 25 Jun 2018 | CONVERSION | XERIS PHARMACEUTICALS INC | 1,557,292 | — | deriv |
| 06 Jul 2016 | CONVERSION | Syros Pharmaceuticals, Inc. | 1,186,654 | — | |
| 06 Jul 2016 | CONVERSION | Syros Pharmaceuticals, Inc. | 508,566 | — | |
| 06 Jul 2016 | PURCHASE | Syros Pharmaceuticals, Inc. | 280,000 | 12.50 USD | |
| 06 Jul 2016 | PURCHASE | Syros Pharmaceuticals, Inc. | 120,000 | 12.50 USD | |
| 06 Jul 2016 | CONVERSION | Syros Pharmaceuticals, Inc. | 1,186,654 | — | deriv |
| 06 Jul 2016 | CONVERSION | Syros Pharmaceuticals, Inc. | 508,566 | — | deriv |
| 08 Feb 2016 | CONVERSION | Editas Medicine, Inc. | 854,700 | — | |
| 08 Feb 2016 | CONVERSION | Editas Medicine, Inc. | 854,700 | — | |
| 08 Feb 2016 | PURCHASE | Editas Medicine, Inc. | 100,000 | 16.00 USD | |
| 08 Feb 2016 | CONVERSION | Editas Medicine, Inc. | 854,700 | — | deriv |
| 08 Feb 2016 | CONVERSION | Editas Medicine, Inc. | 854,700 | — | deriv |
| 23 Oct 2015 | PURCHASE | ALIMERA SCIENCES INC | 12,090 | 3.00 USD | |
| 22 Oct 2015 | PURCHASE | ALIMERA SCIENCES INC | 975 | 3.00 USD | |
| 23 Oct 2015 | PURCHASE | ALIMERA SCIENCES INC | 12,091 | 3.00 USD | |
| 26 Oct 2015 | PURCHASE | ALIMERA SCIENCES INC | 17,116 | 3.00 USD | |
| 26 Oct 2015 | PURCHASE | ALIMERA SCIENCES INC | 17,117 | 3.00 USD |